Medical therapy for rheumatic heart disease: Is it time to be proactive rather than reactive?

Nalini M. Rajamannan, Francesco Antonini-Canterin, Luis Moura, José L. Zamorano, Raphael A. Rosenhek, Patricia J.M. Best, Margaret A. Lloyd, F. Rocha-Gonçalves, Sarat Chandra, Ottavio Alfieri, Patrizio Lancellotti, Pilar Tornos, Ragavendra R. Baliga, Andrew Wang, Thomas Bashore, S. Ramakrishnan, Konstantinos Spargias, Mony Shuvy, Ronen Beeri, Chaim LotanJassim Al Suwaidi, Vinay Bahl, Luc A. Pierard, Gerald Maurer, Gian Luigi Nicolosi, Shahbudin H. Rahimtoola, H. K. Chopra, Natesa G. Pandian

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Medical therapy for rheumatic heart disease: Is it time to be proactive rather than reactive?'. Together they form a unique fingerprint.

Medicine & Life Sciences